Denali Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
70%
€23.00
Target price
30.05.27
€31.00
Performance (%)
-4.35%
End price
14.12.24
€22.00
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Denali Therapeutics Inc. | -6.072% | -6.072% | 36.174% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year